SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma informs about appointment of CS cum CO

07 Jan 2023 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Anuh Pharma has informed that based on the recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company at their meeting held on 6th January, 2023, approved the appointment of Hemant Auti having Membership no. A51703 with effect from 7, January, 2023 as the Company Secretary (CO) and Compliance Officer (CO) of the Company and shall be designated as the Key Managerial Personnel of the Company. Brief profile of Hemant Auti is annexed as an Annexure – A.

The above information is a part of company’s filings submitted to BSE.


Anuh Pharma Share Price

82.80 0.08 (0.10%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×